查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375979

神经復健设备市场规模、份额、趋势分析报告：依产品、治疗领域、地区、细分市场预测，2024-2030

Neurorehabilitation Devices Market Size, Share & Trends Analysis Report By Product (BCI, Wearable Devices, Neurorobotics), By Therapy Area (Stroke, Parkinson's Disease, Cerebral Palsy), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10个工作天内

价格

神经復健设备市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球神经復健器材市场规模将达49.8亿美元，2024年至2030年年复合成长率为13.9%。

更重视重新产品发布的研发、改善患者治疗效果的创新技术和设备的生产以及医疗技术，包括脑机介面 (BCI) 和神经刺激设备等远端医疗假体设备的製造。解决方案等正在推动产业成长。改善患者治疗效果的尖端工具和技术的开拓也推动了市场的成长。不断上涨的医疗成本创造了更多的财政资源来购买最先进的神经復健设备。

神经復健领域的研究和开发资金可以由拥有大量医疗预算的公司获得。因此，可以开发新的和改进的神经復健工具。例如，2023年3月，一家提供智慧康復解决方案的中国公司思亿智能近日透露，宣布获得由涛资本和成都生物城股权投资基金参与的150亿美元A轮投资。公司拟利用这笔资金推动神经復健整合解决方案的研发，打造新型数位復健服务平台。医疗设备製造商、学术机构和医疗保健提供者等主要产业相关人员参与了产品开发的策略合作和伙伴关係。

研究和开发资源可以透过协作结合起来，促进更快的发明和更有效率的产品开发。虚拟实境 (VR) 和 AR 等技术正在用于神经復健。 VR 和 AR 等技术可以设计引人入胜的治疗环境，让患者参与刺激活动，支持运动和认知能力的恢復。治疗师可以透过 VR 和 AR 接收即时回馈。例如，2023 年 4 月，VHA（退伍军人健康管理局）医疗保健创新和学习办公室与专门从事最先进治疗的全球医疗保健公司 Penumbra, Inc. 宣布合作，测试、共同开发和实施基于的復健医疗解决方案

神经復健设备市场报告亮点

  • 2023年，机器人和神经技术的不断进步导致更复杂、更有效的神经机器人设备的开发，神经机器人领域以36.0%的份额占据市场主导地位。
  • 2023年，中风治疗领域占最大收益占有率，达44.3%。家庭神经復健技术的使用正在普及。
  • 透过远端监控和远距復健计划越来越多地提供復健服务，以帮助中风患者在家中方便地继续康復。
  • 2023年北美占全球市场的39.08%。由于新兴企业和少数老牌公司的存在，该区域市场竞争非常激烈。
  • 这些公司努力透过产品创新、合併、收购和联盟来获取更高的产业份额。

目录

第1章调查方法与范围

第2章执行摘要

第3章神经復健设备市场变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 产业价值链分析
    • 赎回框架
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 神经復健设备市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 主要交易及策略联盟分析
    • 打入市场策略

第4章神经復健设备市场：产品估算与趋势分析

  • 定义和范围
  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 全球神经復健设备市场展望（按产品）
  • 2018年至2030年市场规模、预测与趋势分析如下

第5章神经復健器材市场：治疗领域预估及趋势分析

  • 定义和范围
  • 2023 年和 2030 年治疗领域市场占有率
  • 细分仪表板
  • 按治疗领域分類的神经復健设备市场前景
  • 2018年至2030年市场规模、预测与趋势分析如下

第6章神经復健设备市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2023年区域市场占有率和主要企业
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 2018-2030 年市场应用、预测与趋势分析：
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • 创新者
  • 供应商形势
    • Bioventus
    • Ectron
    • Hocoma
    • Medtronic
    • Tyromotion Inc.
    • Abbott
    • Biometrics Ltd
    • Bionik Laboratories Corp.（BNKL）
    • BioXtreme Ltd.
    • Ekso Bionics
    • Saebo, Inc
    • Kinova inc.
    • Kinestica
Product Code: GVR-1-68038-139-9

Neurorehabilitation Devices Market Growth & Trends:

The global neurorehabilitation devices market size is anticipated to reach USD 4.98 billion by 2030, registering a CAGR of 13.9% from 2024 to 2030, according to a new report by Grand View Research, Inc.. Increasing emphasis on R&D for novel product launches, production of innovative technology & devices to enhance patient outcomes, advancements in medical technology, such as manufacturing of neuroprosthetic devices, including brain-computer interfaces (BCIs) and neurostimulation devices, and the increasing adoption of telemedicine & remote rehabilitation solutions drive the industry growth. The development of cutting-edge tools and technologies to improve patient outcomes also drives market growth. Greater financial resources are available to purchase cutting-edge neurorehabilitation equipment when healthcare costs rise.

Funds might be set aside for R&D in the neurorehabilitation sector by business players with sizable healthcare budgets. The development of novel and improved tools for neurological rehabilitation may result from this. For instance, in March 2023, SiYi Intelligence, a Chinese company that offers intelligent rehabilitation solutions, recently revealed that it had raised USD 15 billion in a Series A investment round, with participation from Tao Capital and Chengdu Bio-town Equity Investment Fund. The business intended to use the funds to advance the R&D of neurorehabilitation solution integration and create a new digital rehabilitation service platform. Major industry participants, such as manufacturers of medical devices, academic institutions, and healthcare providers are involved in the strategic collaborations and partnerships for product development.

R&D resources can be combined through collaborative efforts, promoting quicker inventions and the development of more efficient products. The technologies like virtual reality (VR) and AR are being used in neurorehabilitation. They can design therapeutic settings that are engaging, allowing patients to take part in stimulating activities that support the restoration of motor and cognitive abilities. Therapists can receive real-time feedback through VR and AR. For instance, in April 2023, the Office of Healthcare Innovation and Learning of the VHA (Veterans Health Administration) and Penumbra, Inc., a global healthcare company specializing in cutting-edge therapies, announced their collaboration to work together to test, co-develop, and implement VR-based rehabilitative healthcare solutions.

Neurorehabilitation Devices Market Report Highlights:

  • In 2023, the neurorobotics segment dominated the market with a share of 36.0% due to the ongoing advancements in robotics and neurotechnology, which led to the development of more sophisticated and effective neurorobotic devices
  • The stroke therapy area segment held the largest revenue share of 44.3% in 2023. The use of home-based neurorehabilitation techniques is becoming more popular
  • The availability of rehabilitation services is increased via remote monitoring and telerehabilitation programs that enable stroke patients to continue their recovery in the convenience of their homes
  • North America dominated the global market with a share of 39.08% in 2023. The regional market is competitive due to the presence of a few established as well as emerging players
  • These companies strive to capture higher industry shares through product innovations, mergers, acquisitions, and partnerships

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Therapy area
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Therapy area outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Neurorehabilitation Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing incidence of neurological diseases
      • 3.4.1.2. Technological advancements
      • 3.4.1.3. Increasing clinical studies for the neurorehabilitation devices product development
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High cost of devices
      • 3.4.2.2. Complex regulatory framework
  • 3.5. Neurorehabilitation Devices Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Neurorehabilitation Devices Market: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Neurorobotics
    • 4.1.2. Brain-Computer Interface
    • 4.1.3. Wearable Devices
    • 4.1.4. Non-Invasive Stimulators
    • 4.1.5. Others
  • 4.2. Product Market Share, 2023 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Neurorehabilitation Devices Market by Product Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Neurorobotics
      • 4.5.1.1. Neurorobotics market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Brain-Computer Interface
      • 4.5.2.1. Brain-computer interface market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Wearable Devices
      • 4.5.3.1. Wearable devices market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.4. Non-Invasive Stimulators
      • 4.5.4.1. Non-invasive stimulators market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Neurorehabilitation Devices Market: Therapy Area Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Stroke
    • 5.1.2. Parkinson's Disease
    • 5.1.3. Multiple Sclerosis
    • 5.1.4. Cerebral Palsy
    • 5.1.5. Others
  • 5.2. Therapy area Market Share, 2023 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Neurorehabilitation Devices Market by Therapy Area Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Stroke
      • 5.5.1.1. Stroke market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Parkinson's Disease
      • 5.5.2.1. Parkinson's disease market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Multiple Sclerosis
      • 5.5.3.1. Multiple sclerosis market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.4. Cerebral Palsy
      • 5.5.4.1. Cerebral palsy market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.5. Others
      • 5.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Neurorehabilitation Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional market share analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Regional Market Share and Leading Players, 2023
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia Pacific
    • 6.4.4. Latin America
    • 6.4.5. Middle East and Africa
  • 6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
  • 6.6. North America
    • 6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. U.S.
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
    • 6.6.3. Canada
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
  • 6.7. Europe
    • 6.7.1. UK
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive Scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. UK market estimates and forecasts, 2018 - 2030
    • 6.7.2. Germany
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
    • 6.7.3. France
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. France market estimates and forecasts, 2018 - 2030
    • 6.7.4. Italy
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
    • 6.7.5. Spain
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
    • 6.7.6. Denmark
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
    • 6.7.7. Sweden
      • 6.7.7.1. Key country dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory framework
      • 6.7.7.4. Reimbursement scenario
      • 6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
    • 6.7.8. Norway
      • 6.7.8.1. Key country dynamics
      • 6.7.8.2. Competitive Scenario
      • 6.7.8.3. Regulatory framework
      • 6.7.8.4. Reimbursement scenario
      • 6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
  • 6.8. Asia Pacific
    • 6.8.1. Japan
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Competitive Scenario
      • 6.8.1.3. Regulatory framework
      • 6.8.1.4. Reimbursement scenario
      • 6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
    • 6.8.2. India
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. India market estimates and forecasts, 2018 - 2030
    • 6.8.3. China
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. China market estimates and forecasts, 2018 - 2030
    • 6.8.4. South Korea
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory framework
      • 6.8.4.4. Reimbursement scenario
      • 6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
    • 6.8.5. Australia
      • 6.8.5.1. Key country dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory framework
      • 6.8.5.4. Reimbursement scenario
      • 6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
    • 6.8.6. Thailand
      • 6.8.6.1. Key country dynamics
      • 6.8.6.2. Competitive Scenario
      • 6.8.6.3. Regulatory framework
      • 6.8.6.4. Reimbursement scenario
      • 6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
  • 6.9. Latin America
    • 6.9.1. Brazil
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Competitive Scenario
      • 6.9.1.3. Regulatory framework
      • 6.9.1.4. Reimbursement scenario
      • 6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
    • 6.9.2. Mexico
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
    • 6.9.3. Argentina
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
  • 6.10. MEA
    • 6.10.1. South Africa
      • 6.10.1.1. Key country dynamics
      • 6.10.1.2. Competitive Scenario
      • 6.10.1.3. Regulatory framework
      • 6.10.1.4. Reimbursement scenario
      • 6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
    • 6.10.2. Saudi Arabia
      • 6.10.2.1. Key country dynamics
      • 6.10.2.2. Competitive Scenario
      • 6.10.2.3. Regulatory framework
      • 6.10.2.4. Reimbursement scenario
      • 6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
    • 6.10.3. UAE
      • 6.10.3.1. Key country dynamics
      • 6.10.3.2. Competitive Scenario
      • 6.10.3.3. Regulatory framework
      • 6.10.3.4. Reimbursement scenario
      • 6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
    • 6.10.4. Kuwait
      • 6.10.4.1. Key country dynamics
      • 6.10.4.2. Competitive Scenario
      • 6.10.4.3. Regulatory framework
      • 6.10.4.4. Reimbursement scenario
      • 6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Bioventus
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Ectron
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Hocoma
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Medtronic
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Tyromotion Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Abbott
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Biometrics Ltd
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Bionik Laboratories Corp. (BNKL)
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. BioXtreme Ltd.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Ekso Bionics
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Saebo, Inc
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. Kinova inc.
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. Kinestica
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global neurorehabilitation devices market, by region 2018 - 2030 (USD Million)
  • Table 4. Global neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 5. Global neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 6. North America neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 8. North America neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 9. U.S. neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 10. U.S. neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 11. Canada neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 12. Canada neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 13. Europe neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
  • Table 14. Europe neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 15. Europe neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 16. UK neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 17. UK neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 18. Germany neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 19. Germany neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 20. France neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 21. France neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 22. Italy neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 23. Italy neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 24. Spain neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 25. Spain neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 26. Denmark neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 27. Denmark neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 28. Sweden neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 29. Sweden neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 30. Norway neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 31. Norway neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 32. Asia Pacific neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 35. Japan neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 36. Japan neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 37. China neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 38. China neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 39. India neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 40. India neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 41. Australia neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 42. Australia neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 43. Thailand neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 44. Thailand neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 45. South Korea neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 46. South Korea neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 47. Latin America neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
  • Table 48. Latin America neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 49. Latin America neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 50. Brazil neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 51. Brazil neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 52. Mexico neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 53. Mexico neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 54. Argentina neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 55. Argentina neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 56. MEA neurorehabilitation devices market, by country, 2018 - 2030 (USD Million)
  • Table 57. MEA neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 58. MEA neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 59. South Africa neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 60. South Africa neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 63. UAE neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 64. UAE neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)
  • Table 65. Kuwait neurorehabilitation devices market, by product, 2018 - 2030 (USD Million)
  • Table 66. Kuwait neurorehabilitation devices market, by therapy area, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Neurorehabilitation devices market: Market snapshot
  • Fig. 9 Neurorehabilitation devices market: Market segmentation
  • Fig. 10 Neurorehabilitation devices market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Neurorehabilitation devices market driver impact
  • Fig. 14 Neurorehabilitation devices market restraint impact
  • Fig. 15 Neurorehabilitation devices market porter's five forces analysis
  • Fig. 16 Neurorehabilitation devices market PESTEL analysis
  • Fig. 17 Neurorehabilitation devices market segment dashboard
  • Fig. 18 Neurorehabilitation devices market: Product movement Analysis
  • Fig. 19 Neurorobotics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Brain-computer interface market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Wearable devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Non-invasive stimulators market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Neurorehabilitation devices market: Therapy area movement Analysis
  • Fig. 25 Stroke market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Parkinson's disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Multiple sclerosis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Cerebral palsy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Global Neurorehabilitation devices market: Regional movement analysis
  • Fig. 31 Global Neurorehabilitation devices market: Regional outlook and key takeaways
  • Fig. 32 Global market share, by region
  • Fig. 33 North America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 UK market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Germany market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 France market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Italy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Spain market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Japan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 China market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 UAE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)